2012-07-24 12:27:54 UTC

Liver Stiffness Predicts Clinical Outcome in HIV/HCV

July 24, 2012

Liver stiffness predicts clinical outcome in HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis and provides additional prognostic information to that provided by the Child-Turcotte-Pugh score.

Researchers in Spain assessed the predictive value of liver stiffness, measured by transient elastography, for clinical outcome in HIV/hepatitis C virus (HCV)-coinfected patients with compensated liver cirrhosis.

The team found that 8 percent of patients with a baseline liver stiffness less than 40 kPa developed a decompensation versus 29 percent with liver stiffness 40 kPa or more. Factors independently associated with decompensation were Child-Turcotte-Pugh class B versus A, log-plasma HCV RNA load, hepatitis B virus coinfection and baseline liver stiffness.

Child-Turcotte-Pugh class B and previous exposure to HCV therapy were independently associated with liver-related death.

Hepatology 2012: 56(1): 228–238

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Oct. 1, 2017

Among HCV-infected patients treated with DAAs, SVR is associated with a considerable reduction in the risk of HCC; however, the risk for HCC remained high in patients with cirrhosis at the time of SVR.